ADVANCED COURSE Lisbon PORTUGAL. on Oncology/Hematology Therapy September. Centro Cultural de Belém
|
|
- Jane Morrison
- 7 years ago
- Views:
Transcription
1
2 LEARNING OBJECTIVES \ To understand the basic principles of Medical Oncology \ To understand how the main tumour types are approached in the clinic from diagnosis to therapy \ To get closed to the practice of Oncology in a multidisciplinary setting \ To capture the importance of a molecular definition of tumours in the context of a modern precision Medicine CO-CHAIRS Mónica Nave Nazaré Rosado The volume of oncology drug information is expanding exponentially and the need for more emphasis on medication safety monitoring and assurance is imperative. There is an increasing need for specialized and well-trained oncology professionals and it is forecasted that the demand for highly motivated and properly credentialed professional teams in oncology will continue to increase for the foreseeable future! This HCPA Advanced Course aims to dotate professionals with the actual best practice and create opmportunities for knowledge sharing and collaboration!!
3 FACULTY Mónica Nave \ Oncologist at Hospital da Luz, \ Member of the Portuguese Medical Society (Oncology) Nazaré Rosado \ Hospital Pharmacy Specialist - Ordem dos Farmacêuticos \ Lead pharmacist Aseptic Service at Hospital da Luz, Bruno Silva-Santos \ MD, PhD, Post-Doctoral \ Vice-Director of Instituto de Medicina Molecular \ Associate Professor at Faculdade de Medicina da Universidade de Lisboa Marta Soares \ MD, Medical Oncology \ Coordenadora da Unidade de Pulmão, \ Responsável da área médica da Unidade de Sarcomas, IPOPORTOFG John Valgus \ John Valgus, PharmD, BCOP, CPP \ Clinical Specialist, clinic based - Hematology/Oncology Clinic \ Clinical Assistant Professor - UNC Eshelman School of Pharmacy and UNC School of Medicine United States
4 FACULTY Emanuel Gouveia \ MD, Medical Oncology \ IPOLFG, E.P.E. Fábio Lopes \ MD, Medical Oncology \ Hospital Beatriz Ângelo, Lisboa Azucena Aldaz \ Clinical Pharmacist \ Clinica Universidad de Navarra \ Grupo de Farmacia Oncológica de la SEFH Spain Cristina João \ MD \ Haematologist at Fundação Champalimaud, Lisboa \ Faculdade de Ciências Médicas, Universidade Nova de Lisboa Rui Bergantim \ MD \ Haematologist at Hospital São João, Porto \ PhD Student of the Cancer Drug Resistance Group at IPATIMUP
5 SCIENTIFIC PROGRAM DAY 1-15 Sep THE IMPORTANCE OF A MULTIDISCIPLINARY APPROACH Monica Nave, MD Nazaré, PharmD A PRACTICAL REVIEW OF CANCER DIAGNOSIS, STAGING, PROGNOSIS AND THERAPY Monica Nave, MD SYSTEMIC ANTICANCER THERAPY: CLASSIC CHEMOTHERAPY AND TARGETED THERAPY Nazaré, PharmD CANCER IMMUNOTHERAPY Bruno Silva Santos, PhD THERAPY MANAGEMENT ON SOLID TUMORS NSCLC Marta Soares, MD, PT John Valgus, PharmD, US \ Diagnosis and staging \ Adjuvant and neoadjuvant setting \ New approaches oral therapies and immunotherapy \ Managing toxicities \ Clinical Cases Session
6 DAY 2-16 Sep THERAPY MANAGEMENT ON SOLID TUMORS Melanoma Emanuel Gouveia, MD, PT John Valgus, PharmD, US \ Immunotherapy and Target therapy \ The best choice and best sequence \ Managing symptoms and toxicities \ Clinical Cases Session CANCER OF UNKNOWN PRIMARY: A DIAGNOSTIC AND THERAPEUTIC CHALLENGE Fábio Lopes, MD, PT ARE PARP INHIBITORS READY FOR PRIME TIME? Mónica Nave, MD, PT DAY 3-17 Sep THERAPY MANAGEMENT ON HEMATOLOGIC MALIGNANCIES Myelodisplasic Syndromes Azucena Aldaz, PharmD, PhD, SP TBA ( to be announced), MD, US \ Classification, features, diagnosis and treatment options \ New molecules \ Supportive therapy IMMUNOTHERAPY IN HEMATOONCOLOGY Monoclonal Antibodies, Checkpoint Inhibitors and Cart Cells Cristina João, MD, PT Small Molecules (Anti-BTK and Anti-PI3K), Imunomodulation and Transplantation Rui Bergantim, MD, PT
7 SCIENTIFIC COMMITTEE Mónica Nave, MD, Hospital da luz, PT Mª Nazaré Rosado, PharmD, Hospital da luz, PT Fernando FernandezLlimos, FFUL, PT ORGANISING COMMITTEE Andreia Duarte, HCPA Rui Rodrigues, HCPA REGISTRATION (Limited to 30 places) Registration values 2350 euros (VAT included) Venue (Sala Amália Rodrigues), Lisbon, Secretariat Social events Closure dinner on Friday, 16th EVENT OFFICIAL AGENCY Perfect Experiences RNAVT 3965 Rua da Junqueira 200 1º T F E info@perfxp.com flgx
8 is a brand owned by Perfect Experiences. OUR MISSION IS PROMOTING EXCELLENCE IN MEDICINES MANAGEMENT The central objective of HCPA is to promote a complete training program aiming excellence, based on the current best practices of the various areas related to hospital medicines. Our trainings are delivered by recognized national and international health professionals with proven experience.
FCT PhD Programme Medicines and Pharmaceutical Innovation (i3du)
FCT PhD Programme Medicines and Pharmaceutical Innovation (i3du) Course BioPharmaceuticals and Advanced Therapies 28-2 September/October 2015 - Auditorium The FCT PhD Programme in Medicines and Pharmaceutical
More informationProgramme for Advanced Medical Education (Doctoral Programme for Physicians)
Programme for Advanced Medical Education (Doctoral Programme for Physicians) 2011-2012 4 th Edition 1 Programme for Advanced Medical Education The reasons Contemporary Biomedical science provides clinical
More informationScientific Programme
Scientific Programme Scientific Committee Hilary Calvert UCL Cancer Institute, London, UK Luca Gianni Ospedale San Raffaele IRCCS, Milan, Italy Ana Maria Gonzalez-Angulo Cristiana Sessa Istituto Oncologico
More information30-31. Advancesincancer immunologyand immunotherapy. announcement. October2015. Royal Olympic Hotel Athens
Advancesincancer immunologyand immunotherapy 30-31 October2015 Royal Olympic Hotel Athens announcement Organizer Hellenic Oncology Research Group (HORG) Symposium chairs N. Kentepozidis, A. Kotsakis, M.
More informationORGANIZERS Fundación para la Investigación Médica Aplicada FIMA Clínica Universidad de Navarra CUN
D International Symposium: Immunostimulatory monoclonal antibodies and immunomodulation: harvesting the crop Fundación Ramón Areces GENERAL INFORMATION DATES OCTOBER 18th 20th VENUE University of Navarra.
More informationTargeted Therapy What the Surgeon Needs to Know
Targeted Therapy What the Surgeon Needs to Know AATS Focus in Thoracic Surgery 2014 David R. Jones, M.D. Professor & Chief, Thoracic Surgery Memorial Sloan Kettering Cancer Center I have no disclosures
More informationINTERPRETING CLINICAL DATA: Highlights From ASCO 2016
INTERPRETING CLINICAL DATA: Highlights From ASCO 2016 SATURDAY, JUNE 25, 2016 Detroit Marriott - Troy, MI AGENDA Time Topic Speaker 7:30 am Registration and Continental Breakfast 8:00 am Opening Remarks/Welcome
More informationWGO Porto Alegre Hepatology Training Center Information Package
WGO Porto Alegre Hepatology Training Center Information Package Name: Hospital de Clínicas de Porto Alegre Universidade Federal do Rio Grande do Sul Location: Porto Alegre, Brazil Center Director: Mario
More informationFACULDADE DE FARMÁCIA UNIVERSIDADE DE LISBOA
FACULDADE DE FARMÁCIA UNIVERSIDADE DE LISBOA MASTER COURSE BIOPHARMACEUTICAL SCIENCES POST-GRADUATED SPECIALIZATION COURSE Accredited by Agência de Avaliação e Acreditação do Ensino Superior (A3ES) 7 th
More informationEastern North Carolina Lung Cancer Symposium
Eastern North Carolina Lung Cancer Symposium Friday, October 30, 2015 The East Carolina Heart Institute 115 Heart Drive Greenville, North Carolina Jointly Provided by The Department of Internal Medicine
More informationNEOH workshop and 3 rd management committee
Trans-Domain COST Action TD1404 (NEOH) NEOH workshop and 3 rd management committee Faculdade de Ciências Médicas/Nova Medical School (www.fcm.unl.pt) 18 th and 19 th January 2016 This NEOH workshop (in
More informationLauren Berger: Why is it so important for patients to get an accurate diagnosis of their blood cancer subtype?
Hello, I m Lauren Berger and I m the Senior Director of Patient Services Programs at The Leukemia & Lymphoma Society. I m pleased to welcome Dr. Rebecca Elstrom. Dr. Elstrom is an Assistant Professor in
More informationA Career in Pediatric Hematology-Oncology? Think About It...
A Career in Pediatric Hematology-Oncology? Think About It... What does a pediatric hematologist-oncologist do? What kind of training is necessary? Is there a future need for specialists in this area? T
More informationtraining programme in pharmaceutical medicine Regulatory affairs
training programme in pharmaceutical medicine Regulatory affairs INFARMED, Lisbon 19-21 january 2012 Regulatory affairs 19 21 january 2012 LocaL: INFARMED, Lisbon curricular unit Leader: Hélder Mota Filipe,
More informationScientific Committee Hilary Calvert UCL Cancer Institute, London, United Kingdom
Scientific Committee Hilary Calvert UCL Cancer Institute, London, United Kingdom Luca Gianni Fondazione Centro San Raffaele del Monte Tabor, Milan, Italy Ana Maria Gonzalez-Angulo M.D. Anderson Cancer
More informationELCC 2015 Industry Satellite Symposium The Treatment Roadmap for Squamous NSCLC. Thursday 16th April 2015 13:10 14:20 Room C
ELCC 2015 Industry Satellite Symposium The Treatment Roadmap for Squamous NSCLC Thursday 16th April 2015 13:10 14:20 Room C 1 Contents Programme.... 2 Welcome message.... 3 Faculty biographies.... 4 Symposium
More informationUHealth Pharmacy Mission & Vision
UHealth Pharmacy Mission & Vision Our Mission The mission of the department of pharmacy services is to deliver the highest-level pharmaceutical services through safe medication practices, innovative research,
More informationOncology Meetings: Gastric Cancer State of Art March 27 and 28th, 2014
Oncology Meetings: Gastric Cancer State of Art March 27 and 28th, 2014 Meeting Venue: School of Life and Health Science, Minho University Braga, Portugal Campus de Gualtar Room A1 Limited places: 250 places
More informationWORKSHOP IN LUNG CANCER CLINICAL RESEARCH Improving opportunities in the LATAM region
WORKSHOP IN LUNG CANCER CLINICAL RESEARCH Improving opportunities in the LATAM region April 2016 27-30 Santiago - Chile Hotel Diego de Almagro San Pío X 2530, Providencia, Santiago. INFORMATION www.lungcancerworkshop.cl
More informationClinical Trials and YOU
Clinical Trials and YOU What are clinical trials? Controlled studies to determine how a particular anti-cancer strategy ( i.e. treatment ) affects the people who receive it Involve rigorous scientific
More information1 page Overview. CONCURRENT 1D, 1E, 1F Biology & Pathogenesis Multi-Modality Immunology 1
1 page Overview 21 Oct Tuesday 1500 on REGISTRATION 1800 Welcome Reception & Cocktails at the Cape Town International Conference Centre (CTICC) 22 Oct Wednesday 0730 REGISTRATION 0830 OPENING 0900 PLENARY
More informationThe following information is only meant for people who have been diagnosed with advanced non-small cell
Important information for people with advanced non-small cell lung cancer The following information is only meant for people who have been diagnosed with advanced non-small cell lung cancer (NSCLC). NSCLC
More informationSpecific Standards of Accreditation for Residency Programs in Pediatric Hematology/Oncology
Specific Standards of Accreditation for Residency Programs in Pediatric Hematology/Oncology INTRODUCTION 2009 A university wishing to have an accredited program in Pediatric Hematology/Oncology must also
More informationTHE SIDNEY KIMMEL COMPREHENSIVE CANCER CENTER AT JOHNS HOPKINS
Ushering in a new era of cancer medicine Center is ushering in a new era of cancer medicine. Progress that could not even be imagined a decade ago is now being realized in our laboratories and our clinics.
More informationMaster Online Study Program @dvanced Oncology. Study part time team up internationally!
Master Online Study Program @dvanced Oncology Study part time team up internationally! Ulm University is developing an innovative international postgraduate study program @dvanced Oncology addressing clinical
More informationCLINICAL ONCOLOGY MASTERCLASS IN. 25-29 April 2015 São Paulo, Brazil. Chairs: Scientific Co-ordinators: ESO - LATIN-AMERICAN PROGRAMME
ESO - LATIN-AMERICAN PROGRAMME MASTERCLASS IN CLINICAL ONCOLOGY 25-29 April 2015 São Paulo, Brazil Chairs: N. Pavlidis, GR - R.A. Stahel, CH Scientific Co-ordinators: M. Aapro, CH - F. Cardoso, PT FOREWORD
More informationFuture Oncology: Technology, Products, Market and Service Opportunities
Brochure More information from http://www.researchandmarkets.com/reports/296370/ Future Oncology: Technology, Products, Market and Service Opportunities Description: Future Oncology is an analytical newsletter
More information10 th PRACTICAL COURSE
10 th PRACTICAL COURSE PROSTATE ULTRASOUND AND BIOPSY 1 st international workshop on prostate biopsy Final Programme HOSPITAL MILITAR PRINCIPAL April, 29-30, 2010 Objectives Perform Prostate Ultrasound
More informationDaiichi Sankyo to Acquire Ambit Biosciences
For Immediate Release Company name: DAIICHI SANKYO COMPANY, LIMITED Representative: Joji Nakayama, Representative Director, President and CEO (Code no.: 4568, First Section, Tokyo Stock Exchange) Please
More informationCancer Immunotherapy: immune checkpoint inhibitors, cancer vaccines, and adoptive T-cell therapies - Overview
Brochure More information from http://www.researchandmarkets.com/reports/3066973/ Cancer Immunotherapy: immune checkpoint inhibitors, cancer vaccines, and adoptive T-cell therapies - Overview Description:
More informationPromises and challenges of developing new drugs in oncology
3 rd International Michelangelo Conference Promises and challenges of developing new drugs in oncology Chairman: Luca Gianni, Milan I July 2-3, 2015 Venue: Museo della Scienza e della Tecnologia Via San
More informationHouston Cancer Institute
Houston Cancer Institute A personal path to healing Memorial-West Houston Katy Northwest Houston Southeast Houston Sugar Land Convenience for Patients State of the Art Therapies and Diagnosis Real Support
More informationA BRIEF DESCRIPTON OF THE MEDICAL SCHOOL CURRICULA IN BRAZIL
A BRIEF DESCRIPTON OF THE MEDICAL SCHOOL CURRICULA IN BRAZIL 1. The Brazilian Educational System Primary and secondary schooling in Brazil and the United States are similar in terms of student age and
More informationInternational Scientific Cooperation in Neglected Tropical Diseases: Portuguese Participation in EDCTP-2
International Scientific Cooperation in Neglected Tropical Diseases: Portuguese Participation in EDCTP-2 Ricardo Pereira 31 October 2013 Fundação Calouste Gulbenkian, Lisboa Table of Contents 1. Overview
More informationPlease see the LUCADA data manual v3.1.3, available in the downloads section
National Lung Cancer Audit Frequently Asked Questions What dataset should be used? Please see the LUCADA data manual v3.1.3, available in the downloads section What does LUCADA stand for? LUCADA stands
More informationTargeting Specific Cell Signaling Pathways for the Treatment of Malignant Peritoneal Mesothelioma
The Use of Kinase Inhibitors: Translational Lab Results Targeting Specific Cell Signaling Pathways for the Treatment of Malignant Peritoneal Mesothelioma Sheelu Varghese, Ph.D. H. Richard Alexander, M.D.
More informationCancer Clinical trials:
Cancer Clinical trials: All you need to know A booklet for patients with cancer The future of cancer therapy F O R E W O R D If you have cancer, clinical trials may offer you additional treatment options.
More informationPh.D. in Molecular Medicine
Ph.D. in Molecular Medicine and Translational Research College of Medicine 1. Introduction: The College of Medicine, while consolidating on its undergraduate innovative educational programs, decided to
More informationAPIFARMA PORTUGUESE PHARMACEUTICAL INDUSTRY ASSOCIATION
APIFARMA PORTUGUESE PHARMACEUTICAL INDUSTRY ASSOCIATION 2015 ABOUT US Portuguese Pharmaceutical Industry Association Founded in 1975, succeeds the National Guild of the Manufacturers of Medicinal Products
More informationLCFA/IASLC LORI MONROE SCHOLARSHIP IN TRANSLATIONAL LUNG CANCER RESEARCH
LCFA/IASLC LORI MONROE SCHOLARSHIP IN TRANSLATIONAL LUNG CANCER RESEARCH FUNDING OPPORTUNITY DESCRIPTION 2016 REQUEST FOR APPLICATION (RFA) Lung Cancer Foundation of America (LCFA) and the International
More informationResumen Curricular de los Profesores. Jesse Boehm
Resumen Curricular de los Profesores Jesse Boehm Jesse Boehm is the assistant director of the Cancer Program at the Broad Institute. In this role, he works closely with Cancer Program director Todd Golub
More informationPRINCIPLES AND PRACTICES OF MEDICAL DEVICE DEVELOPMENT
0 :: 2 v01 x y p.345 B xxx.:: B A x y pval«««[xy] -løøøø xxx.:: øøøø -0.02-0.01-0.00 0.00 0.01 0.02.1.2 A PHARMATRAIN CENTRE OF EXCELLENCE PRINCIPLES AND PRACTICES OF MEDICAL DEVICE DEVELOPMENT Lisbon,
More informationHigh Grade Gliomas: Update in Treatment and Care Ryan T. Merrell, M.D. Clinical Assistant Professor of Neurology NorthShore University HealthSystem
High Grade Gliomas: Update in Treatment and Care Ryan T. Merrell, M.D. Clinical Assistant Professor of Neurology NorthShore University HealthSystem rmerrell@northshore.org Objectives Provide updates on
More informationE UROPEAN CURRICULUM VITAE FORMAT
E UROPEAN CURRICULUM VITAE FORMAT PERSONAL INFORMATION Name Address VALENTINA GUARNERI University of Padova Dipartimento di Scienze Chirurgiche, Oncologiche e Gastroenterologiche Istituto Oncologico Veneto
More informationUnderstanding series. new. directions. 1-800-298-2436 LungCancerAlliance.org. A guide for the patient
Understanding series LUNG CANCER: new treatment directions 1-800-298-2436 LungCancerAlliance.org A guide for the patient TABLE OF CONTENTS What s New in lung cancer? Advancements...4 Changes in genes that
More informationAAT Portuguese Project
Gabriel Moore Forell Bevilacqua gabrielmoore@gmail.com Assistant Professor Information Science Department Universidade Federal Fluminense (Niterói, Rio de Janeiro, Brazil) Juliana Rodrigues Alves julira@yahoo.com
More informationTeaching Medicine and Teaching Science: Is there a difference? From MD to PhD (Clinical Researcher) Ines Vaz Luis September 2013
Teaching Medicine and Teaching Science: Is there a difference? From MD to PhD (Clinical Researcher) Ines Vaz Luis September 2013 Disclosures I have no disclosures But. I have a WARNING: This talk is largely
More informationReport series: General cancer information
Fighting cancer with information Report series: General cancer information Eastern Cancer Registration and Information Centre ECRIC report series: General cancer information Cancer is a general term for
More informationUpdate in Hematology Oncology Targeted Therapies. Mark Holguin
Update in Hematology Oncology Targeted Therapies Mark Holguin 25 years ago Why I chose oncology People How to help people with possibly the most difficult thing they may have to deal with Science Turning
More informationSORRENTO THERAPEUTICS, INC. (Exact name of registrant as specified in its charter)
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event
More informationTRENDS SHAPING THE FUTURE OF PERSONALIZED CARE AND THE DELIVERY OF SPECIALTY PHARMACY
TRENDS SHAPING THE FUTURE OF PERSONALIZED CARE AND THE DELIVERY OF SPECIALTY PHARMACY Key Takeaways from the June 18, 2013 Regional Symposium Nashville, Tennessee THE SYMPOSIUM Trends Shaping the Future
More informationREPORT ASCO 2002 ORLANDO : LUNG CANCER Johan F. Vansteenkiste, MD, PhD, Univ. Hospital and Leuven Lung Cancer Group
REPORT ASCO 2002 ORLANDO : LUNG CANCER Johan F. Vansteenkiste, MD, PhD, Univ. Hospital and Leuven Lung Cancer Group In the 2002 edition of the ASCO meeting, a total of 315 abstracts in the field of respiratory
More informationColumbia University Program in Physical Therapy Continuing Education
Continuing Education Presents ADVANCES IN EXAMINATION AND TREATMENT OF PATIENTS WITH SELECTED KNEE CONDITIONS: ADVANCES IN EVIDENCE-BASED PRACTICE WHEN Friday, May 8th-Saturday, May 9th, 2015 WHERE Columbia
More informationCommercial Insight: Cancer Targeted Therapies and Immunotherapies -Top monoclonal antibody brands will resist competitive pressures through to 2019
Brochure More information from http://www.researchandmarkets.com/reports/1314569/ Commercial Insight: Cancer Targeted Therapies and Immunotherapies -Top monoclonal antibody brands will resist competitive
More informationTrials in Elderly Melanoma Patients (with a focus on immunotherapy)
Trials in Elderly Melanoma Patients (with a focus on immunotherapy) Where we were Immunotherapy Trials: past and present Relevance for real world practice Where we are SIOG October 2012 James Larkin FRCP
More informationFuture Directions in Clinical Research. Karen Kelly, MD Associate Director for Clinical Research UC Davis Cancer Center
Future Directions in Clinical Research Karen Kelly, MD Associate Director for Clinical Research UC Davis Cancer Center Outline 1. Status of Cancer Treatment 2. Overview of Clinical Research at UCDCC 3.
More informationSommaire projets sélectionnés mesure 29: Soutien à la recherche translationnelle
Sommaire projets sélectionnés mesure 29: Soutien à la recherche translationnelle TITLE PROJET NOM HOPITAL Assessment of tumor angiogenesis using PET/CT with 18 F-Galacto- RGD. (PNC_29_001) Division of
More informationImplementation of a chemotherapy prescribing training programme
Implementation of a chemotherapy prescribing training programme Kumud Kantilal Macmillan Principal Network Pharmacist, Lead for Education & Training kumud.kantilal@gstt.nhs.uk Contents Page 2 Background
More informationNEW CLINICAL RESEARCH OPTIONS IN PANCREATIC CANCER IMMUNOTHERAPY. Alan Melcher Professor of Clinical Oncology and Biotherapy Leeds
NEW CLINICAL RESEARCH OPTIONS IN PANCREATIC CANCER IMMUNOTHERAPY Alan Melcher Professor of Clinical Oncology and Biotherapy Leeds CANCER IMMUNOTHERAPY - Breakthrough of the Year in Science magazine 2013.
More informationXIV ANNUAL MEETING OF NURSING
Archive of Oncology 2000;8(Suppl 1):69. SESSION 5 XIV ANNUAL MEETING OF NURSING 69 Archive of Oncology 2000;8(Suppl 1):70. 70 UDC: 616.34-007.272:616-089.8:614.39 I. GAJI M. ULAFI Æ. MIHAJLOVI R. NE I
More informationPromises and challenges of developing new drugs in oncology
3 rd International Michelangelo Conference Promises and challenges of developing new drugs in oncology Chairman: Luca Gianni, Milan I July 2-3, 2015 Venue: Museo della Scienza e della Tecnologia Via San
More informationHealth Innovation: Future Challenges of Oncology Therapies
PORTUGUESE ASSOCIATION FOR HOSPITAL DEVELOPMENT Health Innovation: Future Challenges of Oncology Therapies Conclusions. Think Health: The Citizen s Access to Therapeutic Innovation Oncology 8 October 2015
More informationAvastin (Renal Cell Carcinoma) - Analysis and Forecasts to 2022
Brochure More information from http://www.researchandmarkets.com/reports/2228475/ Avastin (Renal Cell Carcinoma) - Analysis and Forecasts to 2022 Description: Avastin (Renal Cell Carcinoma) Analysis and
More informationGroundbreaking Collaborative Clinical Trial Launched
Groundbreaking Collaborative Clinical Trial Launched For immediate release Media Contacts: June 16, 2014 Richard Folkers Alison Hendrie 9:00 a.m., EDT Foundation for the NIH Rubenstein Communications (301)
More informationTEACH Summer School Cascais, Portugal 3-7 July, 2016. Training and Education for Advanced Clinicians and HCPs in Personalised Medicine
TEACH Summer School Cascais, Portugal 3-7 July, 2016 Training and Education for Advanced Clinicians and HCPs in Personalised Medicine TEACH Summer School Cascais, Portugal 3-7 July, 2016 Objectives There
More informationHow To Choose A Pediatric Oncologist
Dr. Geoff Cuvelier MD FRCPC Pediatric Oncologist Dr. Cuvelier is a graduate of the Faculty of Medicine, University of Manitoba, and received undergraduate degrees in microbiology and sociology from the
More informationThe Cancer Patient Journey. Dr. Jaco Fourie
The Cancer Patient Journey Dr. Jaco Fourie The Cancer Patient Journey Prevention and health promotion Screening Diagnosis and staging Treatment Surveillance and survivorship End of life care The Cancer
More information8:50 Opening statement - Dr. Felipe José Fernández Coimbra (Head of the Department of Abdominal Surgery, Hospital A. C.
IV SYMPOSIUM OF THE GASTROINTESTINAL ONCOLOGY CONTINUING MEDICAL EDUCATION PROGRAM - DEPARTMENT OF ABDOMINAL SURGERY, SURGICAL ONCOLOGY, A. C. CAMARGO CANCER HOSPITAL ESOPHAGOGASTRIC CANCER AND GIST SCIENTIFIC
More informationCytotoxic and Biotherapies Credentialing Programme Module 2
Cytotoxic and Biotherapies Credentialing Programme Module 2 1. The Cell Cycle 2. Cancer Therapies 3. Adjunctive Therapies On completion of this module the RN will State the difference between a normal
More informationManagement through the
Handbook of Research on Effective Project Management through the Integration of Knowledge and Innovation George Lealjamil Informagöes em Rede, Brazil Sergio Maravilhas Lopes CETAC.MEDIA - Porto and Aveiro
More informationMOLOGEN AG German Equity Forum 2015
German Equity Forum 2015 Dr. Mariola Söhngen Chief Executive Officer Frankfurt am Main 24 November 2015 We are Pioneers in the Field of Immunotherapies Biotechnology company with focus on immunotherapies
More informationPUBLIC NOTICE. In accordance with Articles 37 to 51 and 62 A of ECDU, the following requirements shall apply: I Admission requirements:
PUBLIC NOTICE National and international applications are invited by the Faculty of Sciences of the University of Lisbon, for a period of 30 (thirty) working days from the day immediately following the
More informationCancer services children s CSCF v3.2
Cancer services children s CSCF v3.2 Module overview Please note: This module should be read in conjunction with the Fundamentals of the Framework (including glossary and acronym list), Children s Services
More informationCancer Clinical Trials: In-Depth Information
Cancer Clinical Trials: In-Depth Information The Drug Development and Approval Process 1. Early research and preclinical testing 2. IND application filed with FDA 3. Clinical trials (phases 1, 2, and 3)
More informationCancer treatment. TOP EUROPEAN CANCER EXPERTISE The path to recovery
Cancer treatment TOP EUROPEAN CANCER EXPERTISE The path to recovery 0% LAND OF HIGH QUALITY HEALTHCARE Located in Finland, a land of high quality healthcare, Helsinki University Hospital is regarded as
More informationRobert Bristow MD PhD FRCPC
Robert Bristow MD PhD FRCPC Clinician-Scientist and Professor, Radiation Oncology and Medical Biophysics, University of Toronto and Ontario Cancer Institute/ (UHN) Head, PMH-CFCRI Prostate Cancer Research
More informationSTRATEGY PROGRAM NEXT LEVEL BERLIN, 9 JUNE 2016
STRATEGY PROGRAM NEXT LEVEL BERLIN, 9 JUNE 2016 Disclaimer Certain statements in this presentation contain formulations or terms referring to the future or future developments, as well as negations of
More informationNuevas tecnologías basadas en biomarcadores para oncología
Nuevas tecnologías basadas en biomarcadores para oncología Simposio ASEBIO 14 de marzo 2013, PCB Jose Jimeno, MD, PhD Co-Founder / Vice Chairman Pangaea Biotech SL Barcelona, Spain PANGAEA BIOTECH BUSINESS
More informationThe Brain and Spine CenTer
The Br ain and Spine Center Choosing the right treatment partner is important for patients facing tumors involving the brain, spine or skull base. The Brain and Spine Center at The University of Texas
More informationOncology Central MEDIA PACK 2016 SPONSORSHIP ADVERTISING NETWORKING
Oncology Central MEDIA PACK 2016 SPONSORSHIP ADVERTISING NETWORKING Client opportunities CONTENTS About us...02 Readership...04 Driving qualified leads...05 Our Journals...08 Editorial Calendar...10 Rate
More informationAchievements Report CURING CANCER. Of all the questions addressed to CPRIT, the toughest is: When are you going to find a cure for
Achievements Report August 2015 CURING CANCER Of all the questions addressed to CPRIT, the toughest is: When are you going to find a cure for cancer? Since cancer is complex and comes in many forms, its
More informationCurriculum Vitae of Luca Gianni
Education: 1976: State University of Milan, Milan, Italy: Medical Doctor with honors 1981: State University of Milan, Milan, Italy: Board- Certified in Internal Medicine Brief Chronology of Activities
More informationEuropass Curriculum Vitae
Europass Curriculum Vitae Personal information First name(s) / Surname(s) Address(es) André Morais Correia de Sousa Rua Cassiano Branco, nº 184-4º E 4250-084 Porto Portugal Mobile +351 96 275 3775 E-mail(s)
More informationtargeted therapy a guide for the patient
targeted therapy FOR LUNG CANCER a guide for the patient TABLE OF CONTENTS lung cancer basics... 2-3 Gene changes... 4-5 Testing... 7-8 Targeted therapy... 9-11 Drugs Targeting EGFR... 12 Drugs Targeting
More informationGENETIC PROFILES AND TARGETED TREATMENT OF CANCER - PERSONALIZED MEDICINE
GENETIC PROFILES AND TARGETED TREATMENT OF CANCER - PERSONALIZED MEDICINE Branko Zakotnik MD, PhD Department of Medical Oncology Institute of Oncology Ljubljana 1 I have no conflict of interest to declare
More informationFrom Drug Discovery to First in Humans
0 :: 2 v01 x y p.345 B xxx.:: B A x y pval«««[xy] -løøøø xxx.:: øøøø -0.02-0.01-0.00 0.00 0.01 0.02.1.2 A PharmaTrain Centre of Excellence Non-Clinical Testing, Pharmaceutical & Early Clinical Development:
More informationMedical Oncology. Rotation Goals & Objectives for rotating residents. General Objectives THE UNIVERSITY OF BRITISH COLUMBIA
THE UNIVERSITY OF BRITISH COLUMBIA Department of Urologic Sciences Faculty of Medicine Gordon & Leslie Diamond Health Care Centre Level 6, 2775 Laurel Street Vancouver, BC, Canada V5Z 1M9 Tel: (604) 875-4301
More informationPGY-2 ONCOLOGY PHARMACY RESIDENCY
PGY-2 ONCOLOGY PHARMACY RESIDENCY Program Description and Requirements Providence Health System (PAMC) in Anchorage consists of 394 acute care beds and is part of an integrated health system including
More informationMasters Learning mode (Форма обучения)
Program Title (Название программы): Pharmacology Degree (Степень) Masters Learning mode (Форма обучения) Full-time and part-time Duration of study (Продолжительность программы) 2 years (4 years part time)
More informationThe University of Texas Health Science Center at San Antonio Tobacco Funds Budget Fiscal Year Ending August 31, 2015
Permanent Health Funds for Higher Education (Fund 810) Permanent Health Funds will be assigned to schools to support health education, research programs, and infrastructure operations. Strategy F.1.2.,
More informationAmel Abd Allah Hashim Ahmed
Amel Abd Allah Hashim Ahmed Lecturer of Biochemistry & Molecular Biology PERSONAL PROFILE Nationality: Egyptian Work: Faculty of Pharmacy, Helwan University, Ain-Helwan, Helwan, Egypt. Work phone: 25590000-
More informationOCTOBER 24 and 25, 2014
2014 VII INTERNATIONAL SYMPOSIUM OF THROMBOSIS AND ANTICOAGULATION OCTOBER 24 and 25, 2014 HCOR - RUA DESEMBARGADOR ELISEU GUILHERME, 147 PARAÍSO SÃO PAULO SP BRASIL ORGANIZATION: VII INTERNATIONAL SYMPOSIUM
More informationOvarian Cancer (Event Driven)
Brochure More information from http://www.researchandmarkets.com/reports/2367241/ Ovarian Cancer (Event Driven) Description: Owing to the lack of screening programs across the markets under study, ovarian
More informationSummary of Discussion on Non-clinical Pharmacology Studies on Anticancer Drugs
Provisional Translation (as of January 27, 2014)* November 15, 2013 Pharmaceuticals and Bio-products Subcommittees, Science Board Summary of Discussion on Non-clinical Pharmacology Studies on Anticancer
More informationPortuguese Research Institutions in History
José Luís Cardoso Technical University of Lisbon jcardoso@iseg.utt.pt Luís Adão da Fonseca University of Porto lfonseca@letras.up.pt The growth in historical research in Portugal over the last two decades
More informationGenomic Medicine The Future of Cancer Care. Shayma Master Kazmi, M.D. Medical Oncology/Hematology Cancer Treatment Centers of America
Genomic Medicine The Future of Cancer Care Shayma Master Kazmi, M.D. Medical Oncology/Hematology Cancer Treatment Centers of America Personalized Medicine Personalized health care is a broad term for interventions
More informationHow treatment is planned Giving your consent The benefits and disadvantages of treatment Second opinion
Treatment overview for lung cancer This information is an extract from the booklet Understanding lung cancer. You may find the full booklet helpful. We can send you a free copy see page 5. Contents How
More informationScientific Programme
Scientific Programme Scientific Committee Hilary Calvert UCL Cancer Institute, London, UK Luca Gianni Ospedale San Raffaele IRCCS, Milan, Italy Ana Maria Gonzalez-Angulo The University of Texas, MD Anderson
More information~ icon. cancer care. TGA Submission: Options for reform of the regulatory framework for pharmacy compounding
~ icon cancer care TGA Submission: Options for reform of the regulatory framework for pharmacy compounding Introduction Icon Cancer Care is pleased to have the opportunity to make this submission regarding
More informationCareers in Haematology
Careers in Haematology A Guide for Medical Students and Junior Doctors Haematology is the medical speciality concerned with blood disorders. Your non-medical friends however will always think that you
More information